Trials / Completed
CompletedNCT00399633
Neuropeptides in the Humane Intra- og Extracerebral Circulation.
Neuropeptides in the Humane Intra- og Extracerebral Circulation - in Relation to Sumatriptan in Healthy Volunteers.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Danish Headache Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The study aim at examining whether Sumatriptan changes the plasma values of the neuropeptides vasoactive intestinal polypeptide (VIP), calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase activating peptide (PACAP) and the prostanoids 6-keto-PGF1α, and PGE2, PGD2 og PGF2α.
Detailed description
The study is meant to give a better understanding of the basic mechanisms behind migraine, and a better understanding of the effects of sumatriptan on the trigemino vascular system. The endpoints are changes in the plasma values of the neuropeptides vasoactive intestinal polypeptide (VIP), calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase activating peptide (PACAP) and the prostanoids 6-keto-PGF1α, and PGE2, PGD2 og PGF2α.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sumatriptan |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2007-04-01
- Completion
- 2007-04-01
- First posted
- 2006-11-15
- Last updated
- 2008-05-14
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00399633. Inclusion in this directory is not an endorsement.